How to buy Medibank shares | MPL historical share price and analysis

How to buy Medibank shares

Own Medibank shares in just a few minutes.

We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!

Medibank Private Limited is an insurance-diversified business based in Australia. Medibank shares (MPL) are listed on the Australian Securities Exchange (ASX) and all prices are listed in Australian Dollars. Medibank has a trailing 12-month revenue of around $6.8 billion.

How to buy shares in Medibank

  1. Compare share trading platforms. To buy shares listed in Australia, you'll need to sign up to a broker with access to the Australian Securities Exchange (ASX). Our table below can help you choose.
  2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and tax file number. Fund your account with a bank transfer, PayPal or debit card.
  3. Search for Medibank. Find the share by name or ticker symbol: MPL. Research its history to confirm it's a solid investment against your financial goals.
  4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Medibank reaches your desired price. To spread out your risk, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
  5. Decide on how many to buy. At today's price, weigh your budget against a diversified portfolio that can minimise risk through the market's ups and downs.
  6. Check in on your investment. Congratulations, you own a part of Medibank. Optimise your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

Medibank share price

Use our graph to track the performance of MPL stocks over time.

Medibank shares at a glance

Information last updated 2021-03-28.
52-week range$2.3998 - $3.0267
50-day moving average $2.8643
200-day moving average $2.82
Target priceN/A
PE ratio 22.0611
Dividend yield $0.121 (4.16%)
Earnings per share (TTM) $0.131

Compare share trading platforms

The value of your investments can fall as well as rise and you may get back less than you invested. Past performance is no indication of future results.
Data updated regularly
Name Product Standard brokerage fee Inactivity fee Markets
Superhero share trading
AUD $5
No
ASX shares, ETFs
Pay zero brokerage on all Australian ETFs.
Trade ASX stocks with a flat $5 commission fee and a low minimum investment of just $100.
Bell Direct Share Trading
AUD $15
No
ASX shares, mFunds, ETFs
Exclusive: New customers who open an account with Bell Direct through Finder will pay no brokerage fees on the first five stock or ETF trades until April 30, 2021 (T&Cs apply).
Bell Direct offers a one-second placement guarantee on market-to-limit ASX orders or your trade is free, plus enjoy extensive free research reports from top financial experts.
IG Share Trading
Finder Award
IG Share Trading
AUD $8 or 0.1%
$50 per quarter if you make fewer than three trades in that period
ASX shares, Global shares
$0 brokerage for US and global shares plus get an active trader discount of $5 commission on Australian shares.
Enjoy some of the lowest brokerage fees on the market when trading Australian shares, international shares, plus get access to 24-hour customer support.
ThinkMarkets Share Trading
AUD $8
No
ASX shares, ETFs
Limited offer: Get 5 free ASX trades when you open a new account with ThinkMarkets before June 30, 2021 (T&Cs apply).
Buy and sell CHESS sponsored ASX shares with $0 brokerage on your first 5 trades. Only $8 flat fee brokerage thereafter, plus enjoy free live stock price data on an easy to use mobile app.
CMC Markets Stockbroking
AUD $11 or 0.1%
No
ASX shares, Global shares, mFunds, ETFs
$0 brokerage on global shares including US, UK and Japan markets.
Trade up to 9,000 products, including shares, ETFs and managed funds, plus access up to 15 major global and Australian stock exchanges.
ANZ Share Investing
AUD 19.95
No
ASX shares, Global shares, Options trading, mFunds, ETFs, Warrants
Earn 1 Qantas Point per AU$3 spent on brokerage fees on certain instruments.
Access Morningstar reports, company announcements and and live pricing via ANZ’s share investing platform. Available for desktop and mobile.
Westpac Online Investing Account
AUD 19.95 or 0.11%
USD 63.50 per year on the global markets account
ASX shares, Global shares, Options trading, ETFs
loading

Compare up to 4 providers

Is it a good time to buy Medibank stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Medibank price performance over time

Historical closes compared with the last close of A$2.77

1 month (2021-03-09) -2.12%

Is Medibank under- or over-valued?

Valuing Medibank stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Medibank's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Medibank's P/E ratio

Medibank's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 22x. In other words, Medibank shares trade at around 22x recent earnings.

That's relatively low compared to, say, the P/E ratio for the ASX over the 12 months to December 2019 (32.14). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.

Medibank's EBITDA

Medibank's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $524.3 million (£0.0 million).

The EBITDA is a measure of a Medibank's overall financial performance and is widely used to measure a its profitability.

Medibank financials

Revenue TTM $6.8 billion
Operating margin TTM 7.63%
Gross profit TTM $1.3 billion
Return on assets TTM 9.38%
Return on equity TTM 19.64%
Profit margin 5.32%
Book value 0.675
Market capitalisation $8 billion

TTM: trailing 12 months

Medibank's environmental, social and governance track record

Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like Medibank.

When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.

Medibank's total ESG risk score

Total ESG risk: 20.86

Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and Medibank's overall score of 20.86 (as at 12/31/2018) is pretty good – landing it in it in the 29th percentile of companies rated in the same sector.

ESG scores are increasingly used to estimate the level of risk a company like Medibank is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).

Medibank's environmental score

Environmental score: 3.11/100

Medibank's environmental score of 3.11 puts it squarely in the 1st percentile of companies rated in the same sector. This could suggest that Medibank is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.

Medibank's social score

Social score: 10.91/100

Medibank's social score of 10.91 puts it squarely in the 1st percentile of companies rated in the same sector. This could suggest that Medibank is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.

Medibank's governance score

Governance score: 8.84/100

Medibank's governance score puts it squarely in the 1st percentile of companies rated in the same sector. That could suggest that Medibank is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.

Medibank's controversy score

Controversy score: 2/5

ESG scores also evaluate any incidences of controversy that a company has been involved in. Medibank scored a 2 out of 5 for controversy – the second-highest score possible, reflecting that Medibank has, for the most part, managed to keep its nose clean.

Environmental, social, and governance (ESG) summary

Medibank Private Limited was last rated for ESG on: 2019-01-01.

Total ESG score 20.86
Total ESG percentile 29.38
Environmental score 3.11
Environmental score percentile 1
Social score 10.91
Social score percentile 1
Governance score 8.84
Governance score percentile 1
Level of controversy 2

Medibank share dividends

93%

Dividend payout ratio: 93.08% of net profits

Recently Medibank has paid out, on average, around 93.08% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 4.19% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Medibank shareholders could enjoy a 4.19% return on their shares, in the form of dividend payments. In Medibank's case, that would currently equate to about A$0.121 per share.

Medibank's payout ratio would broadly be considered high, and as such this stock could appeal to those looking to generate an income. Bear in mind however that companies should normally also look to re-invest a decent amount of net profits to ensure future growth.

The latest dividend was paid out to all shareholders who bought their shares by 2 March 2021 (the "ex-dividend date").

Medibank share price volatility

Over the last 12 months, Medibank's shares have ranged in value from as little as $2.3998 up to $3.0267. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (AU average) beta is 1, while Medibank's is 0.4244. This would suggest that Medibank's shares are less volatile than average (for this exchange).

Medibank overview

Medibank Private Limited, an integrated healthcare company, provides private health insurance and health solutions in Australia. The company operates through two segments, Health Insurance and Medibank Health. The Health Insurance segment offers private health insurance products, including hospital cover that provides members with health cover for hospital treatments; and ancillary cover, which offers members with health cover for healthcare services, such as dental, optical, and physiotherapy. This segment also provides health insurance products to overseas visitors and overseas students. The Medibank Health segment offers health management and telehealth services to government and corporate customers, as well as distributes travel, life, and pet insurance products. Medibank Private Limited underwrites its health insurance products under the Medibank and ahm brands. The company was founded in 1976 and is based in Docklands, Australia.

Frequently asked questions

Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, CFDs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading CFDs comes with a higher risk of losing money rapidly due to leverage. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.

More guides on Finder

Ask an Expert

You are about to post a question on finder.com.au:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com.au is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder only provides general advice and factual information, so consider your own circumstances, or seek advice before you decide to act on our content. By submitting a question, you're accepting our Terms of Use, Disclaimer & Privacy Policy and Privacy & Cookies Policy.
Go to site